Welcome to our dedicated page for Caring Brands SEC filings (Ticker: CBRA), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
Caring Brands, Inc. (CBRA) uses SEC filings to document its activities as a Nevada-incorporated issuer of common stock. This page brings together the company’s registration statements, current reports, and related exhibits so that investors can review how Caring Brands, Inc. structures its offerings, interacts with underwriters, and manages its stock exchange listings.
The company’s Form S-1/A registration statements outline a public offering of up to 1,000,000 shares of common stock, par value $0.001 per share, through a firm commitment underwriting. These filings also register additional shares for resale by existing stockholders, including shares issuable upon exercise of warrants that originated in earlier private placements conducted by a related Florida corporation. The S-1/A explains the dual prospectus structure, distinguishing between the public offering prospectus and the resale prospectus, and details items such as use of proceeds, underwriting terms, and risk factors.
A Form 8-K filed by Caring Brands, Inc. reports the execution of the underwriting agreement with D. Boral Capital LLC, the closing of the public offering, and the issuance of an underwriter warrant that allows the underwriter to purchase a specified number of common shares at a fixed exercise price for a multi-year term. The same report notes that the company’s common stock was approved for listing on The Nasdaq Stock Market LLC under the symbol CABR and that trading on Nasdaq commenced on a stated date. Press releases announcing the pricing and closing of the offering are attached as exhibits.
On Stock Titan, each new Caring Brands, Inc. filing from the SEC’s EDGAR system is captured and presented with AI-powered summaries that explain the key points in clear language. Whether you are reviewing an S-1/A amendment, a current report on Form 8-K, or exhibits such as the underwriting agreement and underwriter warrant, the platform highlights essential terms, lock-up provisions, registration rights, and listing details. This helps investors understand how CBRA’s and CABR’s regulatory filings relate to the company’s capital structure and trading status without having to parse every page of the original documents.
Caring Brands, Inc. files its annual report describing a wellness consumer products business that remains in early stages with minimal revenue and significant losses. The company reports a net loss of $6,278,191 for the year ended December 31, 2025, following a net loss of $1,517,431 for 2024, and its auditors raise substantial doubt about its ability to continue as a going concern.
The business centers on over-the-counter and cosmetic products such as Photocil for psoriasis and vitiligo, the Hair Enzyme Booster (JW-700) to enhance minoxidil, and CB-101 for eczema, supported by multiple clinical trials and patents. Licensing agreements with partners including Taisho in Japan and Cosmofix/San Pellegrino in India and other territories underpin its commercialization strategy, while most products use GRASE ingredients under OTC or cosmetic frameworks.
The company is authorized to issue 100,000,000 common shares at $0.001 par value and reports 13,336,925 shares outstanding as of June 30, 2025 and 12,341,506 shares outstanding as of March 30, 2026. Caring Brands qualifies as an emerging growth company and smaller reporting company, using scaled disclosure and extended transition for new accounting standards, and highlights extensive regulatory, competitive, funding, and execution risks.
Caring Brands, Inc. reported two governance changes. The Board amended the company’s bylaws so that stockholders holding thirty-three and one-third percent (33 1/3%) of outstanding capital stock entitled to vote now constitute a quorum for stockholder meetings, instead of a majority. The Board also appointed founder and Chairman Brian John, age 56, to serve as Interim Chief Financial Officer and to act as principal financial officer and principal accounting officer, effective March 30, 2026. As of this filing, his existing compensation arrangements remain unchanged in connection with this interim appointment.
Caring Brands, Inc. director John Brian reported a large share redemption transaction. He disposed of 1,250,000 shares of Common Stock at approximately $1.00 per share in a redemption by the company under a Share Redemption Agreement signed on March 19, 2026. After this disposition to the issuer, he directly holds 750,000 shares of Caring Brands common stock.
Caring Brands, Inc. entered into a $3.6 million private investment in public equity, issuing 3,789.74 shares of Series A Convertible Preferred Stock at $950 per share with a stated value of $1,000 and an 8% dividend. The preferred stock is convertible into common shares at $0.40 and is paired with 9,473,685 common warrants, also exercisable at $0.40 for five years, all subject to beneficial ownership limits and a 19.99% cap without shareholder approval.
The company plans to use $3.075 million of the proceeds to repurchase 6,250,000 common shares from insiders, reducing common shares outstanding from 14,761,925 to 8,511,925, with the balance for general corporate and working capital needs. The investor also obtained an option to invest up to an additional $4.0 million on similar terms and received a 12‑month right of first refusal on future financings, while the company agreed to register the resale of the underlying shares.
Caring Brands, Inc. reported that it has been issued two new United States patents. These patents cover proprietary methods and compositions that enhance enzymatic activity in hair follicles. Management explains that this intellectual property further strengthens protection around its Hair Enzyme Booster product and related technologies, potentially reinforcing its competitive position in hair-focused treatments.
Caring Brands, Inc. completed an initial public offering of 1,000,000 shares of common stock at $4.00 per share, raising approximately $4.00 million in gross proceeds and about $3.23 million in net proceeds. The deal was a firm commitment underwriting with D. Boral Capital LLC and includes a 45-day over-allotment option for up to 150,000 additional shares at the offering price, less the underwriting discount.
As part of the transaction, the underwriter received a warrant to purchase up to 30,000 shares of common stock at an exercise price of $4.00 per share, exercisable for five years starting 180 days after the closing, with up to about 4,500 additional warrant shares if the over-allotment is exercised. Company officers, directors, and 10% holders agreed to a 180-day lock-up on sales of common stock and related securities. The common stock was approved for listing on Nasdaq under the symbol CABR and began trading on November 13, 2025.
Caring Brands, Inc. (CABR) disclosed that its Chief Financial Officer, Tyler Moore, filed an initial insider ownership report on Form 3 in connection with an event dated 10/30/2025. Moore is identified as an officer, specifically the Chief Financial Officer, and the filing is made by one reporting person. In the ownership tables for both non-derivative and derivative securities, the explanation states that no securities are beneficially owned, meaning the CFO reported no direct or indirect holdings of Caring Brands stock or related derivative securities as of the event date.
Caring Brands, Inc.10/30/2025director of the company and beneficially owns 50,000 shares of Caring Brands common stock in direct form. The filing does not list any derivative securities such as options or warrants for this reporting person.
Caring Brands, Inc. (CBRA) reported an initial ownership filing for an insider. The reporting person, Dr. Glynn Wilson, is listed as a director, chief executive officer, and 10% owner of the company. As of the event date of 10/30/2025, Dr. Wilson beneficially owned 2,000,000 shares of common stock, held directly. This Form 3 discloses the insider’s starting ownership position but does not describe any recent stock transactions.
Caring Brands, Inc. director Christopher Melton filed an initial Form 3 stating that he does not beneficially own any of the company’s securities. The filing confirms his status as a director and clarifies that, as of the event date of 10/30/2025, he reports no direct or indirect ownership of either non-derivative or derivative securities of Caring Brands, Inc.